Case report: Toripalimab plus anlotinib in postoperative recurrent renal pelvic sarcomatoid urothelial carcinoma

BackgroundSarcomatoid urothelial carcinoma (SUC) is a rare renal malignancy. Its biological malignancy is high, the prognosis is poor, diagnostic and treatment options are few, and there is no standard treatment plan.Case presentationIn this case, a 64-year-old woman was hospitalized with fever and...

Полное описание

Библиографические подробности

Главные авторы:	Xinrong Hu, Lin Deng, Yufei Pan, Guozhen Zhang, Xiaolan Ruan, Xinlan Jiang, Hao Shen, Lei Zhao, Jun Dong
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2024-09-01
Серии:	Frontiers in Oncology
Предметы:	toripalimab anlotinib postoperative recurrence renal pelvic urothelial carcinoma upper-tract urothelial carcinoma sarcomatoid urothelial carcinoma
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1397855/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!